<DOC>
	<DOCNO>NCT00769223</DOCNO>
	<brief_summary>RATIONALE : Gathering information Gleason score , prostate-specific antigen ( PSA ) level , cancer stage patient undergone radiation therapy prostate cancer may help doctor predict patient respond treatment help plan best treatment . PURPOSE : This clinical trial study Gleason score , PSA level , cancer stage predict outcome patient undergone radiation therapy localize prostate cancer .</brief_summary>
	<brief_title>Predicting Risk Failure Patients Undergoing Radiation Therapy Localized Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate value pre-operative Gleason score , prostate-specific antigen level , clinical stage predict risk failure death patient undergone radiotherapy localize prostate cancer . OUTLINE : This multicenter study . Patient medical record review collect data pre-treatment prostate biopsy , assign Gleason score , prostate-specific antigen level , radionucleotide bone scan . Patients complete Bowel Toxicity questionnaire ass quality life relate acute long-term bowel toxicity radiotherapy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis localize adenocarcinoma prostate Has undergone radiotherapy ( external beam radiotherapy and/or brachytherapy ) without hormonal therapy adenocarcinoma prostate UCSF Radiation Oncology Department San Francisco General Hospital Veterans Administration Medical Center San Francisco 1987 2006 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>radiation toxicity</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>adenocarcinoma prostate</keyword>
</DOC>